
Omalirel Injection
Marketer
Reliance Life Sciences
Salt Composition
Omalizumab (150mg)
Overview Omalirel Injection
Xolair is a targeted antibody therapy indicated for moderate-to-severe asthma management in adults and pediatric patients. It alleviates common asthma symptoms like wheezing, shortness of breath, chest tightness, and cough. Xolair is administered via injection under medical supervision; initial doses are given by a healthcare professional. Following training, self-administration at home may be possible, as determined by your physician. Dosage is individualized to optimize symptom control, and continuous use, as directed, is crucial even with symptom improvement. Frequently reported side effects include arthralgia, pain, fatigue, vertigo, bone fracture, pruritus, skin rash, upper abdominal discomfort, rhinitis, cephalalgia, and otalgia. Report any concerning or persistent side effects to your doctor; management strategies may be available. Importantly, Xolair doesn't prevent acute asthma exacerbations; always keep your rescue inhaler readily accessible. Prior to initiating treatment, disclose any liver or kidney conditions, pregnancy, or pregnancy plans. Comprehensive disclosure of all concurrent medications is essential, as interactions can affect Xolair's efficacy or mechanism of action. Alcohol consumption is generally discouraged during treatment.
Uses of Omalirel Injection
Chronic obstructive pulmonary disease
Major Benefits of Omalirel Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Omalirel Injection:
- Joint pain
- Pain
- Fatigue
- Dizziness
- Fracture
- Itching
- Dermatitis
- Upper abdominal pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Ear pain
How to use Omalirel Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.
How Omalirel Injection works:
Omalizumab injection is a targeted antibody therapy that neutralizes immunoglobulin E proteins, key mediators of asthma.
SAFETY ADVICE
AlcoholSAFE
Omalirel Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The administration of Omalirel Injection during pregnancy is typically deemed safe. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies remain scarce.
Breast feedingCONSULT YOUR DOCTOR
Administration of Omalirel via injection during lactation is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Omalirel Injection.
KidneySAFE IF PRESCRIBED
The use of Omalirel Injection in individuals with kidney disease appears to present minimal risk. Current evidence indicates dose modification may be unnecessary for this population; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Omalirel Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dose modification may not be necessary for this population. Physician consultation is recommended.
What if you forget to take Omalirel Injection :
NA
Facts to Know About Omalirel Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Action Category | Monoclonal anti-IgE antibodies |
